Steminent Biotherapeutics Inc. (TPEX:7729)
83.70
+0.50 (0.60%)
Jun 18, 2026, 2:59 PM CST
300.48% (1Y)
| Market Cap | 5.58B +344.7% |
| Revenue (ttm) | n/a |
| Net Income | -174.04M |
| EPS | -2.95 |
| Shares Out | 66.63M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 221,818 |
| Open | 81.60 |
| Previous Close | 83.20 |
| Day's Range | 81.60 - 84.10 |
| 52-Week Range | 19.80 - 95.60 |
| Beta | 0.18 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jun 24, 2026 |